4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001246360-16-007221
CIK 0001333170operating
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:28 PM ET
Size
4.8 KB
Accession
0001246360-16-007221
Insider Transaction Report
Form 4
Giannini Daniel A
Director
Transactions
- Sale
Common Stock
2016-11-21$25.96/sh−6,449$167,416→ 63,193 total
Footnotes (1)
- [F1]This represents the weighted average price for shares sold in multiple transactions at prices ranging from $25.82 to $26.12, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 6:28 PM ET
- Size
- 4.8 KB